Log In

Cocrystal Pharma Inc. (COCP)

FY2022 Reported With New Clinical Trials On Track

‌
Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
March 30, 2023
Report ID: 25715
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.
Get Report

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

‌
Cocrystal Pharma Inc.
Cocrystal Pharma Inc.
Healthcare
Biotechnology
Ticker
COCP
Current Price
$1.96 -7.98%
Market Cap
$19.9M
Price Target
Refer to Report
Volume
12.1K
52wk Range
$1.74 - $3.72
Fundamental Analysis:
Log in to view
Rating: Log in to view
Advanced Market Data
Related Research Reports
8/15/2023
‌
2Q23 Reported With New Clinical Trials Ready To Begin
2Q23 Reported With New Clinical Trials Ready To Begin (COCP)
0 min read
5/15/2023
‌
Products Are Advancing Toward Clinical Milestones
Products Are Advancing Toward Clinical Milestones (COCP)
8 min read
3/30/2023
‌
FY2022 Reported With New Clinical Trials On Track
FY2022 Reported With New Clinical Trials On Track (COCP)
0 min read
12/20/2022
‌
Safety and Tolerability Data From Influenza Study Announced
Safety and Tolerability Data From Influenza Study Announced (COCP)
0 min read

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
Log In
© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.
Log In